Ravi Ramesh Pathak

Baylor College of Medicine

Papers

1

Total Citations

2

H-Index

1

About

Ravi Ramesh Pathak is a translational immunologist whose research focuses on harnessing the immune system to combat human papillomavirus (HPV)-associated oropharyngeal cancers (HPVOPC). His key contributions lie in understanding how immunotherapies reshape the tumor microenvironment and peripheral immune landscape. In his landmark “window of opportunity” trial, Pathak investigated the effects of ADXS11-001, a Listeria-based immunotherapy targeting the HPV E7 antigen, administered prior to robotic surgery in HPV-positive oropharyngeal cancer patients. This work provided critical insights into how such therapies alter local and peripheral T cell diversity, offering a mechanistic rationale for combining immunotherapy with surgical intervention. Though early in his career, Pathak’s work is foundational for the emerging field of neoadjuvant immunotherapy in virally driven head and neck cancers. His research bridges immunology and clinical oncology, with implications for improving outcomes in patients with limited treatment options. Pathak’s contributions are particularly notable for their direct translational impact, demonstrating how basic immunological principles can be applied to real-time patient care.

Research Focus

Key Achievements

1
H-Index
1
Papers
2
Total Citations
2
Avg Citations/Paper
🏆 Most Cited Paper
Abstract 5639: Changes in local and peripheral T cell diversity after HPV E7 antigen-expressing Listeria-based immunotherapy (ADXS11-001) prior to robotic surgery for HPV-positive oropharyngeal cancer
2 citations · 2018
📈 Most Prolific Year: 2018 (1 Papers)
🤝 Key Collaborators: 14
🏛 Institutions: Baylor College of Medicine

Top Papers

  1. 1

Key Collaborators

Contact & Links

Available for collaboration
Content generated · 11 days ago